Contineum Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for neuroscience, inflammation and immunology (NI&I) indications with high unmet need. Contineum targets biological pathways associated with specific clinical disabilities, that once modulated, can demonstrably impact the course of disease. 

Biotechnology

Life Sciences

Neuroscience

Pharmaceutical

Therapeutics

Contineum Therapeutics

Carmine Stengone

Varsha Dourado

Daniel S. Lorrain

Stephen L. Huhn

Peter Slover

Jules Lee

Didier Bagnol

Chris Baccei

Leadership Team

Clinical Operations Team

Teams at Contineum Therapeutics

Leadership Team

Clinical Operations Team